Citeline (formerly Pharma Intelligence) powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory related-decisions and create real-world opportunities for growth. Citeline’s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and MedTech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.
Employees: 201-500
Founded date: 1997
Investors 1
| Date | Name | Website |
| 22.07.2022 | Warburg Pi... | warburgpin... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 15.06.2023 | Hemophilia Federation of America Launches Clinical Trial Fin... | NEW YORK (PRWEB) June 15, 2023 In an effort to make relevant clinical trials more accessible to pati... | prweb.com/... |
| 01.12.2022 | Citeline Announces Winners of the 2022 Scrip Awards, Recogni... | LONDON (PRWEB) December 01, 2022 At a live ceremony held Wednesday night in London, Citeline announc... | prweb.com/... |
| 29.06.2022 | Norstella and Citeline plan merger, seek to bring critical m... | Norstella and Citeline plan merger, seek to bring critical medications to patients faster Norstella,... | kmworld.co... |
| 28.06.2022 | Citeline and Norstella Unite to Offer Life Sciences Clients ... | The new organization will help life sciences companies improve strategic decision-making and acceler... | realwire.c... |
| 29.06.2016 | What will separate the winners and the losers in the immuno-... | But it does raise long term strategic and capital allocation questions for cancer R&D. This blog... | medcitynew... |
| - | What will separate the winners and the losers in the immuno-... | I/O: The strategic supernova in cancer today With the big cancer confab ASCO 2016 fading into memory... | medcitynew... |